pN+ | AUS positive | AUS negative | p | ||
---|---|---|---|---|---|
n | n | % | |||
Age (years) | n.s. | ||||
≤50 | 28 | 16 | 12 | 42.9 | |
>50 | 138 | 63 | 75 | 54.3 | |
BMI | n.s. | ||||
<25 | 60 | 28 | 32 | 53.3 | |
25-29.9 | 59 | 24 | 35 | 59.3 | |
≥30 | 46 | 26 | 20 | 43.5 | |
Tumour stage | 0.001 | ||||
pT1 | 62 | 20 | 42 | 67.7 | |
pT2 | 81 | 42 | 39 | 48.1 | |
pT3 & pT4 | 23 | 17 | 6 | 26.1 | |
Histological subtype | n.s. | ||||
Ductal | 128 | 66 | 62 | 48.4 | |
Lobular | 16 | 5 | 11 | 68.8 | |
Others | 22 | 8 | 14 | 63.6 | |
Grading | 0.005 | ||||
G1 | 6 | 1 | 5 | 83.3 | |
G2 | 88 | 34 | 54 | 61.4 | |
G3 | 72 | 44 | 28 | 38.9 | |
Lymphangiosis | 0.001 | ||||
No | 33 | 7 | 26 | 78.8 | |
Yes | 133 | 72 | 61 | 45.9 | |
Growth pattern | n.s. | ||||
Unifocal | 139 | 65 | 74 | 53.2 | |
Multicentric | 25 | 14 | 11 | 44.0 | |
ER status | 0.024 | ||||
Positive | 129 | 55 | 74 | 57.4 | |
Negative | 37 | 24 | 13 | 35.1 | |
PR status | 0.014 | ||||
Positive | 109 | 44 | 65 | 59.6 | |
Negative | 57 | 35 | 22 | 38.6 | |
HER2 status | 0.007 | ||||
Negative | 150 | 66 | 84 | 56 | |
Positive | 16 | 13 | 3 | 18.8 | |
Ki-67 | <0.001 | ||||
≤14% | 38 | 9 | 29 | 76.3 | |
>14% | 122 | 69 | 53 | 43.4 | |
Total | 166 | 79 | 87 | 52.4 |